NURS 1566 Clinical Form 3: Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Name Trade Name Classification Dose Route Time/frequency

Montelukast Singulair Pharmacologic: 10 mg Po Q morning
leukotriene
antagonists
Peak Onset Duration Normal dosage range
3-4 hr within 24 hr 24 hr 10 mg once daily

Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
for asthma N/A

Mechanism of action and indications Nursing Implications (what to focus on)

(Why med ordered) Contraindications/warnings/interactions
Action: Antagonizes the effects of leukotrienes, which mediate the Contraindicated if there is a hypersensitivity. Use cautiously in Acute
following: Airway edema, Smooth muscle constriction Altered attacks of asthma, Hepatic impairment (may need lower doses),
cellular activity; Result is decreased inflammatory process. Indicated Reduction of corticosteroid therapy (may increase the risk of eosinophilic
for prevention and chronic treatment of asthma. Indicated for conditions). Drugs which induce the CYP450 enzyme system
prevention and chronic treatment of asthma. (phenobarbital and rifampin ) may decrease the effects of monteleukast
Common side effects
CNS: fatigue, headache, weakness, EENT: otitis (children), sinusitis
(children), Resp: cough, rhinorrhea, GI: abdominal pain, diarrhea
(children), dyspepsia, nausea (children), increased liver enzymes,
Derm: rash, Misc: EOSINOPHILIC CONDITIONS (INCLUDING
CHURG-STRAUSS SYNDROME), fever
Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine
medicines (ask patient specifically) May cause ↑ AST and ALT concentrations
none
Be sure to teach the patient the following about this
medication
take medication daily in the evening, even if not experiencing symptoms
of asthma. Do not double doses. Do not discontinue therapy without
consulting health care professional. montelukast is not used to treat acute
asthma attacks, but may be continued during an acute exacerbation.
Patient should carry rapid-acting therapy for bronchospasm at all times.
Advise patient to notify health care professional if more than the
maximum number of short-acting bronchodilator treatments prescribed
for a 24-hr period are needed
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving
Lung sounds, respiratory function, and allergy med? In case of allergy
symptoms. In case of allergy